Editorial: Thyroid Carcinoma

Thyroid carcinoma is the commonest endocrine malignancy and accounts for approximately 1% of all malignancies. Approximately 34000 new cases are diagnosed each year in USA. Majority of diagnosed patents are women making thyroid carcinoma as the seventh most common female malignancy. Outcome in thyroid carcinoma is very variable ranging from clinically insignificant disease to a very aggressive disease. Overall the prognosis of thyroid carcinoma is good with an excellent disease free survival. Hundahl SA et al reported ten year relative survival rate based on total cohort of 53,856 patients in USA of 93% for papillary and 85% for follicular carcinomas. Theincidence of thyroid carcinoma is increasing but some of it is due to early detection secondary to appropriate management of thyroid nodules.